Portfolio Press
The following press items contain more information about our portfolio companies and/or the medical issues they’re currently addressing.
Fund I: Alydia Health
(Acquired June 2021 by Organon)
Fund I: AmplifiDx
Fund I: Antiva Biosciences
Fund I: AOA Dx
Fund I: Avation Medical
Fund II: Axena Health
Fund I: Candesant Biomedical
Fund II: Clarified Precision Medicine
Fund I: Curio
Fund I: Dahlia Biosciences
Fund II: Elucent Medical
Fund II: ENB Therapeutics
Fund I: Genome Medical
Fund I: Madorra
Fund I & Fund II: Meet Mae
Fund I: Midi Health
Fund I: Raydiant Oximetry
Fund I: Uqora
(Acquired July 2021 by Pharmavite)
Fund I: ViuHealth
February 28, 2024: Alydia mentioned in Deloitte’s analysis of the women’s health market
December 21, 2023: Alydia mentioned in an article covering women’s health
October 13, 2023: Colby Holtshouse receives Pulse-Setting Trailblazer Award on behalf of the Jada® System
February 10, 2023: Real-world study shows that Alydia’s Jada® System is safe and highly effective
February 7, 2023: Organon calls for recognition for the repercussions of underinvesting in women’s health
December 28, 2022: The commercial pathway of a life-saving medical device shows the gender biases holding back women’s health. Note: membership required for viewing.
August 26, 2022: De-risking and self-advocacy are keys to changing women’s health research and development
May 12, 2022: Rob Binney joins ShiraTronics Inc. as new CEO
January 7, 2022: 8 health and medicine milestones from 2021
December 15, 2021: Organon’s Kevin Ali named one of Comparably’s best CEOs of 2021
October 19, 2021: Organon’s Susi Fiedler on surmounting women’s health challenges
October 11, 2021: Organon receives FDA clearance for technological updates to the Jada® System
September 22, 2021: Sharon Vosmek of Astia Angels: how making money can be an articulation of your values
July 5, 2021: Cal Poly HotHouse company started as a senior project. It just sold for $240M.
June 16, 2021: Organon completes acquisition of Alydia Health
June 15, 2021: Organon shows how women’s health can be fertile ground for investment. Here’s why.
May 4, 2021: Alydia’s Jada System named one of Fast Company’s World Changing Ideas
April 27, 2021: Paul Praino named VP of Sales
April 27, 2021: Colby Holtshouse is a panelist for JNJ Innovation’s “Game Changers for Innovating in Maternal Health” panel
March 30, 2021: Alydia Health acquired for up to $240M
March 8, 2021: Alydia Health named one of Fierce Medtech’s 2020 Fierce 15. (Read Alydia’s feature here.)
February 13, 2021: Northeast Georgia Medical Center receives life-saving technology for new moms
February 1, 2021: Treating PPH: A novel, vacuum-induced hemorrhage control device
January 25, 2021: How to learn more about Alydia at SMFM 2021
December 30, 2020: FDA clearance for Alydia’s Jada is one of Healio’s top women’s health stories of 2020
October 30, 2020: BU’s Alumna Spotlight: Kathryn Wine, VP of Clinical Operations at Alydia Health
October 20, 2020: Alydia named among industry leaders in Postpartum Hemorrhage Treatment Device Market research report
October 14, 2020: Alydia among winners of JNJ Innovation’s Maternal Health QuickFire Challenge
October 4, 2020: Jada named among Cleveland Clinic Innovation’s Top 10 medical innovations for 2021
September 16, 2020: Alydia board member, Erica Rogers, among winners of Entrepreneur Of The Year® Award in Northern California
September 9, 2020: Alydia Health announces FDA clearance and publication of pivotal study
September 9, 2020: Alydia’s Pivotal Study: Intrauterine Vacuum-Induced Hemorrhage-Control Device for Rapid Treatment of Postpartum Hemorrhage
September 3, 2020: The Jada System for Postpartum Hemorrhage: Interview with Rob Binney, CEO of Alydia Health
July 30, 2020: Alydia announces new funding and new leadership appointments
February 24, 2020: Alydia appoints CMO
February 5, 2020: Alydia completes pivotal trial enrollment
January 10, 2020: Alydia appoints new board member
January 2, 2019: New device to stop postpartum bleeding could save lives
December 21, 2018: Interview: Anne Morrissey & MedTech
September 28, 2018: Passing the torch at Alydia Health
September 28, 2018: Alydia announces $10 million financing
Click here to read more about Alydia Health.
January 21, 2024: Nancy Shoenbrunner is a speaker at the Annual Non-Dilutive Funding Summit
May 23, 2023: AmplifiDx receives $1.4M NIH RADx grant
May 25, 2021: COVID-19’s impact on laboratory medicine management
May 18, 2021: AmplifiDx is a RESI Pitch Challenge finalist
September 8, 2020: Public health officials pursue Covid-19 tests that trade precision for speed
July 22, 2020: Quest Diagnostics warns of new Covid-19 testing crunch in autumn
February 27, 2024: Life Science Leader: Antiva is a company to watch
December 5, 2023: Antiva featured in SVB’s “Innovation in Women’s Heath 2023” report
October 19, 2023: Antiva makes key new leadership appointments
September 14, 2023: Gail Maderis is a speaker at the 2023 Women’s Health Innovation Summit
August 15, 2023: Antiva featured in SVB’s “Healthcare Investments and Exits” update
April 27, 2023: Antiva announces $53M round and new CEO
September 4, 2022: Antiva among the 24 startups pitching at the 2022 Women’s Health Innovation Summit
January 5, 2022: Antiva Biosciences named one of the winners of The Global Women’s HealthTech Awards
November 2, 2021: Antiva Biosciences closes $31M round
April 21, 2021: Antiva appoints Clifford Samuel to Board of Directors
January 27, 2020: Gail Maderis on D&I in biotech
November 9, 2018: Antiva’s Gail Maderis finds inspiration in today’s biotech innovation
November 8, 2018: San Francisco Business Times names Gail Maderis one of the most admired CEOs
August 16, 2018: A woman’s health startup tried to drum up interest for a much-needed drug. Many men didn’t get it.
April 10, 2024: Five start-ups shortlisted for Women’s Cancer Innovation award
March 26, 2024: Oriana Papin-Zoghbi makes the 2024 TITAN 100 list (Read the corresponding press release here.)
March 22, 2024: Way to detect ovarian cancer being developed in Denver
March 13, 2024: Biotech company focused on early ovarian cancer detection opens in Denver Note: membership required for viewing.
March 8, 2024: Could this startup turn the tide on ovarian cancer?
December 21, 2023: Oriana Papin-Zoghbi quoted in an article covering women’s health
December 20, 2023: Three essentials when raising capital (by Oriana Papin-Zoghbi)
December 8, 2023: AOA’s biomarker diagnostic effectively screens 90% of patients with early-stage ovarian cancer
December 5, 2023: AOA featured in SVB’s “Innovation in Women’s Heath 2023” report
October 31, 2023: AOA published in Frontiers of Oncology
October 12, 2023: AOA raises $17M round
September 28, 2023: AOA featured in The Wall Street Journal Note: membership required for viewing.
September 19, 2023: AOA hosts panel on prioritizing DEI in clinical trials
September 14, 2023: Oriana Papin-Zoghbi is a speaker at the 2023 Women’s Health Innovation Summit
August 23, 2023: Bloomberg New Economy announces 2023 Class of Catalysts. Note: membership required for viewing. Watch the corresponding video here.
August 15, 2023: AOA featured in SVB’s “Healthcare Investments and Exits” update
May 31, 2023: The Top Founders and Leaders Driving Innovation in Women’s Health in 2023
May 26, 2023: Top female entrepreneurs disrupting women’s health and fertility
May 19, 2023: Startup radar: VCs on femtech startups worth watching
April 16, 2023: LifeSci Beat Podcast with Oriana Papin-Zoghbi (also available on Apple, SoundCloud, and Spotify)
April 11, 2023: AOA announces publication of first peer-reviewed clinical study (Read the corresponding press release here.)
April 5, 2023: Female founders in tech fireside chat and mixer
April 4, 2023: “5 on Funding” with Oriana Papin-Zoghbi
April 3, 2023: AOA among the 25 startups pitching at the 2023 Women’s Health Innovation Summit – Europe
March 17, 2023: Five femtech startups leading the fight against cancer
March 17, 2023: Five femtech startups leading the fight against cancer
March 14, 2023: Oriana Papin-Zoghbi is featured on NBC Bay Area
February 16, 2023: Oriana Papin-Zoghbi is a speaker at the Wharton Health Care Business Conference
February 13, 2023: The Project Medtech podcast: how to take advantage of programs for startups
January 24, 2023: Despite 2022’s headwinds, women’s health startups did better than ever before
January 5, 2023: AOA announces first patient enrollment in OVERT clinical trial
January 4, 2023: Female founders are energizing investment in women’s healthcare
December 8, 2022: AOA is one of the 23 startups to watch in Boston in 2023 Note: membership required for viewing.
December 6, 2022: AOA announces initial validation of tumor gangliosides
December 1, 2022: Oriana Papin-Zoghbi is one of Women of Wearables’ 200 Trailblazing Leaders
November 8, 2022: Build a cap table and understand dilution impact of early-stage investment webinar
November 7, 2022: AOA sweeps the Eddies
October 17, 2022: AOA is one of the 35 most promising femtech startups, according to VCs. Note: membership required for viewing.
October 12, 2022: Oriana Papin-Zoghbi is a speaker at the 2022 Hispanic Innovation and Entrepreneurship Program
October 6, 2022: Female life science leaders share stories and advice at the Boston Business Journal event. Note: membership required for viewing.
October 5, 2022: Legally Femtech: Femtech Investment and Fundraising Strategy with Oriana Papin-Zoghbi
October 1, 2022: Orian Papin-Zoghbi and Anna Milik Jeter honored in Inc.’s Top Female Entrepreneurs of 2022
September 29, 2022: AOA wins the Women’s Health Innovation Showcase
September 22, 2022: Oriana Papin-Zoghbi is one of the speakers at Startup Boston Week
September 21, 2022: AOA is pitching at the MassChallenge Early Stage Startup Showcase
September 19, 2022: Fempower Health podcast: Emerging femtech for Ovarian Cancer Awareness Month
September 13, 2022: The intersection between innovation and clinical advancement in women’s health
September 8, 2022: Oriana Papin-Zoghbi is among the finalists for the BWB Awards
September 4, 2022: AOA among the 24 startups pitching at the 2022 Women’s Health Innovation Summit
August 5, 2022: AOA selected for MassChallenge’s 2022 Early-Stage Cohort
July 22, 2022: Eight tips for achieving your goals (and setting a positive example for your team)
June 28, 2022: The next scientific revolution (Note: Oriana’s section starts at 1:44)
June 23, 2022: Busine$$ of the V podcast: This femtech startup is developing better ovarian cancer diagnostics
June 9, 2022: AOA chosen as 2022 Eddies finalist by the Massachusetts Innovation Network
May 19, 2022: 3 things to remember when diversifying your startup’s cap table (by Oriana Papin-Zoghbi). Note: membership required for viewing.
April 29, 2022: How small businesses can compete in a heated job market
March 17, 2022: How technology can help end suffering in silence: Endometriosis, PCOS, and gynecological cancers
March 16, 2022: Meet seven femtech companies innovating in ovarian, breast, and gynecological cancers & health
March 10, 2022: WoW Woman: Oriana Papin-Zoghbi
March 9, 2022: Femtech founders share their insights on the space
February 14, 2022: Surbhi Sana joins AOA’s Board of Directors
February 9, 2022: On the couch with Oriana Papin-Zoghbi
January 24, 2022: Life Science Innovation Podcast by Enventure with Anna Milik Jeter
January 12, 2022: 'Women Building for Women' with Oriana Papin-Zoghbi
January 11, 2022: Three things to consider when searching for the right co-founders (by Oriana Papin-Zoghbi)
December 31, 2021: AOA published in The Journal of Precision Medicine
December 20, 2021: AOA among 2021 MedTech IGNITE winners
December 2, 2021: I was pregnant while involved in Y-Combinator. Here’s how I navigated this incredibly difficult but fulfilling time (by Oriana Papin-Zoghbi). Note: membership required for viewing.
November 18, 2021: AOA among female-led life science companies presenting at Springboard Enterprises’ Demo Day
November 17, 2021: Oriana Papin-Zoghbi joins Tech4Eva’s roadshow as a panelist
November 11, 2021: Angel Invest Boston: Oriana Papin-Zoghbi of AOA
October 27, 2021: Women’s Health Innovation Forum: Women’s Oncology
October 26, 2021: Seven business opportunities that need more female voices
October 8, 2021: Female founders share about their journeys, discuss diversity
October 6, 2021: Oriana Papin-Zoghbi of AOA (YC S21)
September 14, 2021: 20 cutting-edge women’s health inventions to watch
September 13, 2021: How to raise money to fund an underserved space (by Oriana Papin-Zoghbi)
September 10, 2021: BIOMEDevice Boston will feature presentations by MassMEDIC Ignite 2021 cohorts
August 31, 2021: Here are all the companies from Y Combinator’s Summer 2021 Demo Day Part I
August 16, 2021: AOA’s Chief Scientific Officer awarded $650,000 grant for further liquid biopsy test development
August 13, 2021: Best practices for executing a successful product launch (by Oriana Papin-Zoghbi)
August 2, 2021: AOA signs exclusive license agreement to secure suite of IP
July 9, 2021: Oriana Papin-Zoghbi accepted into Forbes’ Young Entrepreneur Council
June 28, 2021: AOA announces $2.5M seed round
June 24, 2021: FemTech Founder: an interview with Oriana Papin-Zoghbi
June 22, 2021: Inception with Oriana Papin-Zoghbi
June 16, 2021: AOA announces $87,500 in non-dilutive funding
June 14, 2021: FemTech Focus podcast: AOA Dx.
May 24, 2021: AOA chosen for 2021 IGNITE cohort
May 20, 2021: AOA & Professor H. Uri Saragovi awarded $100,000 grant
May 20, 2021: FemTech company aims to revolutionize ovarian cancer detection & survival rates
May 5, 2021: AOA files patent for composition and methods of ovarian cancer diagnosis
January 4, 2021: AOA announces exclusive option agreement
January 4, 2021: AOA announces partnership with Professor H. Uri Saragovi for blood test’s development and commercialization
January 4, 2021: Professor Uri Saragovi and Dr. Anne-Marie Mes-Masson win grant to help enable early cancer detection
May 24, 2019: Recognizing great ideas at the McGill Clinical Innovation Competition
Click here to read more about AOA Dx
April 26, 2024: Jill Schiaparelli is a finalist for EY’s Entrepreneur Of The Year® 2024 East Central Award
April 19, 2024: Avation hires VP of market access and payer relations
April 17, 2024: This device treats overactive bladder without drugs or surgery
April 6, 2024: Dr. Goudelocke discusses Vivally in the Urology Times
March 4, 2024: Avation Medical achieves Certification of Accreditation from The Compliance Team™
February 27, 2024: Medical Design Briefs: A breakthrough in wearable neuromodulation
February 20, 2024: Avation unveils Vivally at the 2024 SUFU Conference
February 1, 2024: Avation raises $22M
January 21, 2024: Overactive Bladder Treatment Report highlights Avation
November 15, 2023: Avation’s results published in Urology
August 30, 2023: Using digital to develop devices with the patient in mind (by Jill Schiaparelli)
May 4, 2023: Avation wins most innovative wearable award
April 11, 2023: Avation announces FDA 510(k) clearance for its Vivally® System
December 1, 2022: Avation Medical is at the intersection between neuromodulation and personalized medicine
October 5, 2022: The top 25 healthcare technology leaders of Houston in 2022
September 29, 2022: “The Cutting Edge of Digital Health” panel
June 14, 2022: Avation presents at the American Urogynecologic Society (AUGS) annual meeting
April 13, 2022: Avation appoints Chief Marketing Officer
January 11, 2022: Jill Schiaparelli named one of the top 25 women leaders in medical devices of 2022
December 8, 2021: Avation announces Board of Director appointments
August 5, 2020: Webinar: Female Leaders in Uncertain Times (featuring Jill Schiaparelli) Note: membership or payment required for viewing.
November 17, 2019: Urinary incontinence is common and often treatable - but hard to discuss
July 15, 2019: Global urinary incontinence device market expected to reach $4.8b by 2026
December 12, 2018: Nocturia overactive bladder improved with PTNS
Click here to read more about Avation Medical
March 8, 2024: ‘Indomitable Spirit’ spurs incontinence treatment from Axena
March 8, 2024: Axena publishes report on urinary incontinence in Sub-Saharan Africa (Read the corresponding press release here.)
March 4, 2024: Axena announces new insurance code for Leva®
January 23, 2024: Axena commends study showing Leva®’s long-term treatment efficiency
January 22, 2024: Axena launches study to explore barriers to incontinence care
January 21, 2024: Leva®’s results published in International Urogynecology Journal
January 9, 2024: Axena partners with four new distributors
December 6, 2023: Female incontinence: a public health crisis? (by Dr. Samantha Pulliam)
December 5, 2023: Axena featured in SVB’s “Innovation in Women’s Heath 2023” report
October 7, 2023: Data shows Leva®’s long-term value
October 2, 2023: Axena’s Leva® is one of AARP’s 2023 Breakthroughs in Women’s Health
August 15, 2023: Axena featured in SVB’s “Healthcare Investments and Exits” update
June 22, 2023: International Urogynecological Association grants “Best Overall Abstract Presentation” to researchers studying Leva®
June 20, 2023: Leva® cleared for chronic fecal incontinence
May 17, 2023: Axena Health begins global study into female incontinence
March 22, 2023: Cigna Healthcare adds the Leva® Pelvic Health System as a covered treatment
March 1, 2023: Axena publishes one-year longitudinal follow-up in Obstetrics and Gynecology
February 20, 2023: Axena raises $25M Series A
September 23, 2023: Brella™ wins Allure’s 2023 Best of Beauty Breakthrough Award
June 6, 2023: Candesant announces $35M Series B financing
April 19, 2023: Doris Day MD discusses hyperhidrosis and Brella™
April 13, 2023: The FDA just approved a new patch for excessive sweating: an interview with Allure
April 13, 2023: Candesant’s Brella™ receives FDA clearance
March 18, 2023: Candesant’s pivotal clinical study shows significant reduction in underarm sweating through patch
March 9, 2023: Candesant announces oral presentation of pivotal clinical trial data
December 19, 2022: This innovative patch could stop your excessive underarm sweat
October 6, 2022: Candesant Biomedical introduces novel investigational technology for hyperhidrosis
September 20, 2022: A pilot study of the safety and effectiveness of a novel device in subjects with axillary hyperhidrosis
May 27, 2021: Healthtech Leader of the Month: Niquette Hunt
March 8, 2021: Niquette Hunt elected to California Life Science Association’s Board of Directors
October 16, 2020: The ultimate list of private medtech companies to watch
September 10, 2020: Candesant Biosciences: MedTech
Innovation Best Video Competition
June 26, 2020: 20 medical device startups you need to know
June 22, 2020: MedTech Innovator picks 50 startups for accelerator program
October 25, 2018: Candesant Biomedical announces safety and efficacy data
Click here to read more about Candesant Biomedical.
April 19, 2024: Clarified sees seed investment as sign that market recognizes gaps
April 16, 2024: Clarified Precision Medicine announces new raise and new CEO
August 19, 2023: A serial entrepreneur and cancer survivor pitches precision medicine startup on “Closing Time”
August 23, 2022: Myriad Genetics partners with Clarified Precision Medicine
August 10, 2022: VieCure integrates the Clarified Precision Medicine process within its platform
September 22, 2021: The Carcinoid Cancer Foundation partners with Clarified Precision Medicine
August 13, 2021: Clarified Precision Medicine acquires Interpares Biomedicine
Click here to read more about Clarified Precision Medicine.
April 24, 2024: Curio receives FDA approval for MamaLift Plus
October 6, 2023: Curio’s pivotal trial meets efficacy endpoints
August 15, 2023: Curio featured in SVB’s “Healthcare Investments and Exits” update
July 27, 2023: Curio is a 2023 Prix Galien USA nominee
May 31, 2023: The Top Founders and Leaders Driving Innovation in Women’s Health in 2023
March 8, 2023: Startek partners with Curio to offer MamaLift program
February 15, 2023: Curio was chosen as a finalist for the Reproductive Health Innovation Showcase
December 22, 2022: Curio was chosen as the VentureFuel 2022 Venture of the Year
December 14, 2022: Curio is a VentureFuel 2022 Venture of the Year finalist
December 6, 2022: Contextualizing digital therapeutics for women’s health: a podcast episode with Shailja Dixit
October 17, 2022: Curio is one of the 35 most promising femtech startups, according to VCs. Note: membership required for viewing.
October 6, 2022: Curio is exhibiting at the Propelify Innovation Festival
September 16, 2022: Shailja Dixit featured on “Women to Watch with Sue Rocco”
August 25, 2022: Curio publishes results from its latest Human Factor Trial
June 30, 2022: Curio partners with Axia Women’s Health to support patients with postpartum depression
June 29, 2022: Women’s Health Forum: Cognitive & Brain Health
May 24, 2022: Shailja Dixit joined VentureFuel’s ‘What’s Next Now: Health and Wellness’
May 23, 2022: Shailja Dixit and Curio featured on “The Balancing Act”: a Lifetime TV program
January 11, 2022: Curio selected as a finalist for the Reproductive Health Innovation Summit
December 15, 2021: Women of Community Shoutout: Shailja Dixit
September 30, 2021: Digital Interventions in Healthcare
July 30, 2021: Women's Health with Curio and Organon
July 15, 2021: Digital Women’s Health: Status Quo and Future Expectations
June 25, 2021: Interview with Eliza Ng of Curio Digital Therapeutics
March 26, 2021: Interview with Shailja Dixit of Curio Digital Therapeutics
September 28, 2023: Genesis of CRISPR’s molecular scissors
October 7, 2020: Nobel Prize in Chemistry goes to CRISPR/Cas9 discoverers
November 29, 2019: Dahlia Biosciences’ tech further validated
April 24, 2018: Indie Bio - Demo Day: Dahlia Biosciences
Click here to read more about Dahlia Biosciences.
April 10, 2024: Elucent Medical secures Series C funding
January 3, 2024: Elucent Medical and Lovell announce partnership
August 23, 2023: Unleashing the power of precision to transform patient care
June 29, 2023: Elucent announces new CEO and CFO
June 28, 2023: Elucent Medical named one of the 10 most influential companies of the year
April 24, 2023: Elucent Medical is presenting at ASBrS 2023
April 13, 2023: First in Minnesota: Park Nicollett Methodist Hospital incorporates Elucent’s technology
April 3, 2023: The impact of an electromagnetic seed localization device versus wire localization on breast-conserving surgery
January 21, 2023: Elucent Medical is presenting at STS 2023
May 12, 2021: UConn Health utilizing Elucent’s EnVisio™ Surgical Navigation system
January 20, 2021: St. Mary’s hospital is the first in the world to use Elucent Medical’s SmartClip™
January 4, 2021: Fox Chase Center is using a new, revolutionary tool in cancer treatment
January 17, 2020: Dr. Lee Wilke helps lead company revolutionizing tumor location
November 18, 2019: How Laura King grew a risky startup while following her passion for clinical care
April 12, 2019: FDA clears EnVisio™ Surgical Navigation system
December 27, 2023: 12 women-led biotech companies that crushed it in 2023
November 7, 2023: ENB announces top-line Phase 1B study results
July 18, 2023: ENB Therapeutics announces completed enrollment for Phase 1 trial
February 8, 2023: The Checkpoint Inhibitor Refractory Cancer market should see continued growth
February 6, 2023: ENB Therapeutics is presenting at the 2023 BIO CEO & IO 360⁰ Conferences
November 4, 2022: ENB Therapeutics is presenting at the 2022 Summit for Cancer Immunotherapy
May 24, 2022: ENB Therapeutics announces Orphan Drug Designation for ENB-003
February 1, 2021: ENB Therapeutics demonstrated early efficacy in Phase I clinical trial of ENB-003
November 17, 2020: ENB-003 receives IND approval
February 4, 2019: ENB Therapeutics announces clinical trial collaboration with Merck to evaluate ENB-003
September 20, 2018: ENB Therapeutics closes Series-A financing round
August 25, 2023: Genome Medical wins Brandon Hall Group HCM Excellence Silver Award
August 24, 2023: Driving growth and expanding downstream service opportunities with virtual genetic services: a conversation with Jill Davies
August 16, 2023: Genome Medical recognized as one of America’s fastest growing companies on the 2023 Inc 5000 list
June 22, 2023: Gundersen Health System expands genetic program with Genome Medical’s telegenetic counseling services
May 25, 2023: Genome Medical supporting Beam Therapeutics on sickle cell disease clinical trial
May 3, 2023: Genome Medical wins Genomics Innovation Award
March 29, 2023: Accelerating clinical trials and sponsored testing programs using telegenetics: a Genome Medical webinar
March 6, 2023: Genome Medical is at the Molecular & Precision Med TRI-CON 2023
February 15, 2023: Genome Medical and xCures announce partnership
December 29, 2022: The Life Science Tools Market Report 2022
October 26, 2022: Genome Medical is at the 2022 American Society of Human Genetics annual meeting
September 29, 2022: Lisa Alderson is a speaker at the Illumina Genomics Forum
September 28, 2022: Genome Medical selected as quarterfinalist for the UCSF Health Awards
September 21, 2022: Lisa Alderson is a conversation leader at the Health Innovation Summit
September 20, 2022: Genome Medical and Pierian announce collaboration to optimize genetic testing programs
August 18, 2022: Colleen Caleshu, MS, LCGC presents on practical applications of genetic information
August 9, 2022: Genome Medical partners with the Hereditary Neuropathy Foundation for CMT Genie Project
July 19, 2022: The human genetics market
June 30, 2022: Genome Medical is presenting at the Precision Medicine World Conference 2022
June 16, 2022: Gender affirming care in genetic counseling
June 9, 2022: The business case for investing in genomics
May 23, 2022: Lisa Alderson joins Adela Inc.’s Board of Directors
May 20, 2022: Providing personalized medicine: reflections from representatives of differently structured healthcare systems
May 13, 2022: Utilizing public health frameworks and partnerships to ensure equity in DNA-based population screening
May 6, 2022: Genome Medical’s Betsy Swope, MS, CGC presents at the Illinois Society of Genetic Professionals Annual Symposium
May 5, 2022: Myriad Genetics, a Genome Medical partner, reports first quarter results
March 14, 2022: Raise the Bar Smart Money podcast: Lisa Alderson - Force For Good
March 8, 2022: Genome Medical named one of America’s best startup employers
January 10, 2022: The Pharmacy Podcast interviews Dr. Gillian Bell, Pharmacogenomics Lead at Genome Medical
December 18, 2021: Genome Medical’s Scott Weissman on team behind NSGC’s Lynch Syndrome Practice Resource
December 15, 2021: Genome Medical partners with GRAIL to provide access to a multi-cancer early detection blood test
December 9, 2021: Genome Medical joins coalition supporting Seven Bridge Genomics’ Unified Patient Network
December 8, 2021: Genome Medical is one of the CB Insights’ top digital health companies of 2021
November 17, 2021: Genetic Testing for Stomach Cancer Webinar: The Who, What, Where and Why You Should Be Tested
November 2, 2021: A day in the life of Maria-Renee Coldagelli, one of Genome Medical's genetic counselors
October 11, 2021: Genome Medical partners with Invitae and Outcomes4Me
September 27, 2021: Genomic Medicine: how to go from cutting edge to commonplace for all
September 13, 2021: Genome Medical announced as quarterfinalist in New Application in Telehealth category for USCF Health Awards
September 9, 2021: Accelerate what's "right": best practices for implementing best-in-class genetic & genomic care and research
August 30, 2021: Genome Medical announces acquisition of GeneMatters and closing of $60M Series C financing
August 18, 2021: Physician-directed genetic screening to evaluate personal risk for medically actionable disorders
August 4, 2021: Genome Medical’s Molly McGinniss MS, CGC elected as ACGC President
July 15, 2021: Tracxn’s Top Diagnostic Tech Startups
May 20, 2021: Four ways genomics will advance clinical care (by Lisa Alderson)
April 29, 2021: Genome Medical’s exclusive licensing of Health Heritage helps accelerate virtual genomic medicine delivery
April 14, 2021: PTC Therapeutics, Genome Medical, and Invitae partnering for PTC Pinpoint Direct™ Program
March 31, 2021: Genome Medical expands Board of Directors and Leadership Team
March 11, 2021: The Next Wave with Young Sohn: Genomics & the Future of Healthcare with Lisa Alderson
February 2, 2021: 5 Key Trends in Digital Health for 2021 - and 10 Companies to Watch
February 1, 2021: Genome Medical wins “Best Digital Health Company to Work For” award
January 30, 2021: Healthcare Trends That Will Rule 2021
January 26, 2021: Slice of Healthcare: Lisa Alderson
December 15, 2020: Webinar: Reimaging Population Health Management
November 20, 2020: Genetic Counseling for All
November 19, 2020: Genome Medical reaches 90 million covered lives in U.S
November 9, 2020: Genomics is evolving from niche to center stage
October 5, 2020: Health Podcast Network: Lisa Alderson
September 21, 2020: Global genomic medicine market competitive landscape outlook: 2020-2027
August 24, 2020: Top Women in Precision Medicine: Lisa Alderson
August 20, 2020: This entrepreneur raised $60M to bring genetics to everyday life
August 14, 2020: Understanding your personal and genetic health: an interview with Genome Medical
August 13, 2020: Genome Medical on CB Insights’ 2020 list of digital health front-runners
July 9, 2020: The versatility of telehealth (ft. Lisa Alderson)
July 1, 2020: Genome Medical aims to plug a genetics gap
July 1, 2020: Genome Medical announces $14M round
June 30, 2020: Genome Medical is leading the way
June 10, 2020: Genome Medical celebrates fourth anniversary
March 31, 2020: Should everyone have their full genome sequenced?
March 25, 2020: Of Known Significance: genomics-driven healthcare
March 10, 2020: Interview: Lisa Alderson
February 12, 2020: 5th International Day of Women and Girls in Science Assembly: Lisa Alderson
January 30, 2020: Lisa Alderson is the inaugural recipient of the Tom Main Health Innovation Mentorship
Click here to read more about Genome Medical.
January 16, 2024: Will there be a little blue pill for postmenopausal women?
December 5, 2023: Madorra featured in SVB’s “Innovation in Women’s Heath 2023” report
August 15, 2023: Madorra featured in SVB’s “Healthcare Investments and Exits” update
February 15, 2023: Madorra’s device could offer a new non-hormonal treatment for vaginal atrophy
February 7, 2023: Madorra’s positive pilot study results are published in the journal “Menopause” (Read the corresponding press release here.)
December 7, 2022: Madorra is joining MATTER 51 Labs’ inaugural cohort
November 20, 2022: Busine$$ of the V podcast: Restoring vaginal vibrancy without hormones
June 20, 2022: WashU women changing the way we live and work
June 16, 2022: 3 ways to become a more effective board member (featuring Christina Jenkins, a Madorra board member)
March 15, 2022: Why design thinking is crucial for medical device innovation: an interview with Holly Rockweiler
February 23, 2022: Holly Rockweiler co-hosts AOBIO’s “Life & Biosciences Sector Map”
February 15, 2022: UCSF Rosenman Institute’s Healthtech Leader of the Month: Holly Rockweiler
December 1, 2021: Madorra selected for inaugural Series P accelerator
November 9, 2021: Holly Rockweiler graduates from the Ferolyn Fellowship program
November 1, 2021: Madorra named one of Oregon’s top wellness startups
October 12, 2021: Sham-controlled study finds no significant improvement from lasers in vaginal symptoms for women with vaginal atrophy symptoms
September 28, 2021: Holly Rockweiler featured on Oregon Bioscience Incubator’s “Future of Femtech” social hour
September 24, 2021: Madorra’s trial data presented at NAMS
September 8, 2021: FDA grants Madorra breakthrough device designation status
July 20, 2021: Let’s improve the health of women, period.
May 20, 2021: Madorra wins FemAging pitch competition
May 5, 2021: Spotlight: Holly Rockweiler, Ferolyn Fellow
April 28, 2021: Holly Rockweiler is a panelist for the Women’s Health Innovation Forum: Gynecology & Sexual Health. (Watch the replay here.)
April 19, 2021: The $10 billion business of perimenopause
April 8, 2021: How Tech Is Making Menopause a No-Sweat Lifestage
March 23, 2021: Madorra selected to present at Cooley’s Capital Call fundraising event
March 17, 2021: Holly Rockweiler featured on Women’s Health Tech Wednesdays
February 1, 2021: Madorra mentioned in interview with Trish Costello of Portfolia
November 19, 2020: Holly Rockweiler moderates Oregon Bio Digital Conference’s “The Road to Successful Exits” panel
October 15, 2020: Holly Rockweiler featured on HLTH’s “Opening Minds & Doors to Opportunity in Femtech” panel
September 30, 2020: Madorra abstract featured in the North American Menopause Society’s Virtual Annual Meeting (Note: membership required for viewing. You can also find a written summary of the oral abstract presentations here. Madorra is S-8.)
July 1, 2020: Holly Rockweiler featured on NCI’s “How to Prepare and Perfect Your Pitch” panel
June 26, 2020: Madorra named winner at angel investing innovation showcase
June 25, 2020: Holly Rockweiler featured on OHSU’s Customer Outreach panel
June 19, 2020: Madorra mentioned in Forbes’ “Menopause Journey” article
May 2, 2020: Madorra featured in O Magazine’s May issue
April 2, 2020: Interview: Holly Rockweiler & Golden Seeds
February 27, 2020: Portland Tribune features Madorra
February 26, 2020: Overwhelming interest in Madorra
January 8, 2020: Madorra mentioned in Forbes’ “FemTech in 2020” article
May 20, 2019: Interview: Holly Rockweiler & UCSF
April 23, 2019: Top 100 Women in FemTech and HealthTech
Click here to read more about Madorra.
February 13, 2024: Maya Hardigan is a panelist at the Reproductive Health Innovation Summit
December 18, 2023: Aetna Better Health of Illinois announces partnership with Mae
December 5, 2023: Mae featured in SVB’s “Innovation in Women’s Heath 2023” report
June 5, 2023: How doulas are advancing maternal health outcomes
May 19, 2023: Startup radar: VCs on femtech startups worth watching
April 20, 2023: Aetna Better Health of Maryland announces pilot program with Mae
March 21, 2023: Where mom is served wholly with Maya Hardigan
February 15, 2023: Top 10 U.S-based Black business founders to watch in 2023
February 15, 2023: Mae was chosen as a finalist for the Reproductive Health Innovation Showcase
February 15, 2023: Maya Hardigan is a speaker at the Reproductive Health Innovation Summit
February 10, 2023: Maya Hardigan sits down with ‘Momtourage’
February 2, 2023: Mae was named a 2023 New York Digital Health 100 company
February 1, 2023: Mae is hosting a webinar on the disparities facing expectant Black women
January 23, 2023: 19 female-focused women’s health startups founded by women
January 12, 2023: Meet the Nasdaq Entrepreneurial Center’s Winter 2023 Milestone Makers Cohort
October 17, 2022: Mae is one of the 35 most promising femtech startups, according to VCs. Note: membership required for viewing.
July 27, 2022: Women’s Health Forum: Reproductive Health
May 20, 2022: Rock Health report finds that women turned to digital health tools in 2021
April 14, 2022: Women working to end Black maternal health crisis
March 30, 2022: Meet the Black women behind the new digital startups aimed at reducing health disparities
March 9, 2022: Femtech founders share their insights on the space
February 22, 2022: PitchBook’s Notable & Quotable: Maya Hardigan
February 14, 2022: 66 Black founders and investors to watch in 2022
January 24, 2022: Future-proofing health through inclusive innovation
December 7, 2021: New research consortium to tackle maternal health disparities with digital technologies
October 13, 2021: Maya Hardigan is one of the female founders leading the way in healthcare innovation in New York
September 28, 2021: Inception with Mike Edelhart: Maya Hardigan, CEO of Mae
September 27, 2021: California bill aims to reduce deaths among black mothers
September 15, 2021: Mae among awardees of QuickFire Challenge
September 8, 2021: Maternal health platform Mae launches with $1.3M
January 17, 2021: Launched - Mae: a maternal health tech platform for black expectant mothers
June 27, 2019: Venture Partner Perspectives: Maya Hardigan
Click here to read more about Meet Mae.
April 30, 2024: Midi is building a digital platform for an often-overlooked area of women’s health
April 30, 2024: How Midi raised millions for a menopause-focused platform
April 24, 2024: Midi featured in The New York Times
April 24, 2024: Midi announces Series B round
April 23, 2024: Getting great menopause care - with Joanna Strober
April 19, 2024: What’s Your Story? with Joanna Strober
April 17, 2024:A $100m investment in women’s healthcare isn’t enough. This is what we need instead (co-written by Joanna Strober)
April 15, 2024: Reframing the conversation around menopause to make progress in the workplace
April 1, 2024: A doctor who gets midlife health care should be easier to find - with Joanna Strober
April 1, 2024: The midlife women’s care gap with Joanna Strober
March 19, 2024: Midi partners with Neurotrack
March 14, 2024: Midi and Cleo join forces
March 11, 2024: Menopause in the Workplace
February 18, 2024: Startups enter the $18 billion menopause market
February 12, 2024: Passionate Pioneers with Mike Biselli: Joanna Strober
January 23, 2024: Yes We Can with Joanna Strober
January 19, 2024: Midi is raising a $60M Series B round Note: membership required for viewing.
January 16, 2024: Midi partners with Ambience Healthcare
December 22, 2023: Joanna Strober quoted in article about tech company holidays Note: membership required for viewing.
December 18, 2023: Midi is a health startup that will take off in 2024, according to VCs Note: membership required for viewing.
December 5, 2023: Midi featured in SVB’s “Innovation in Women’s Heath 2023” report
November 24, 2023: Gwyneth Paltrow namedrops Midi
November 19, 2023: NBC Bay Area on offering menopause care
November 14, 2023: Joanna Strober is an Emerson Collective Dial Fellow
November 9, 2023: Thinking of implementing a menopause benefit? Consider these tips.
November 9, 2023: Menopause discussions are coming into the open, with a boost from celebs
November 7, 2023: The Health Care Blog spotlights Joanna Strober
November 2, 2023: Now’s the time to bring up menopause at work. Here’s why.
November 1, 2023: Joanna Strober: Exploring gaps in menopausal healthcare
October 30, 2023: Midi announces plans for 50 state availability for employers
October 18, 2023: Midi partners with Memorial Hermann Health System
October 12, 2023: Fortune’s Most Powerful Women Summit 2023: Menopause and the Workplace
September 27, 2023: Midi announces $25M round (Note: membership required for viewing. You can also read the corresponding press release here.)
August 15, 2023: Midi featured in SVB’s “Healthcare Investments and Exits” update
August 4, 2023: Progyny unveils nationwide access to menopause care
August 2, 2023: Joanna Strober is one of Forbes’ 50 Over 50
July 17, 2023: How telehealth startups are trying to fill the menopause care vacuum
May 31, 2023: The Top Founders and Leaders Driving Innovation in Women’s Health in 2023
April 19, 2023: Closing the gender healthcare gap: how digital health can transform care for 50% of the world’s population
April 11, 2023: Midi’s Kathleen Jordan, MD, quoted in article about Oprah and menopause
April 5, 2023: Happy 40th Birthday, Now Read This: A Menopause Cheat Sheet (by Jill Herzig, Midi’s Co-Founder and Chief Brand Officer)
April 5, 2023: “The Menopause Talk” with Oprah, Drew Barrymore, Maria Shriver, Sharon Malone, MD, and Heather Hirsch, MD. Note: membership required for viewing.
March 29, 2023: Operator Collective PortCo Profile: Midi Health
March 21, 2023: I’m a Silicon Valley Bank customer but I’m no “tech bro” (by Joanna Strober). Note: membership required for viewing. (Listen to the corresponding interview here)
March 4, 2023: Joanna Strober is a speaker at the American Telemedicine Association’s Annual Conference & Expo 2023
February 14, 2023: Lifepoint Health® and Midi announce collaboration
February 9, 2023: The business of menopause
February 1, 2023: Women have been misled about menopause
December 12, 2022: My Career Path: an interview with Midi CTO Jaikumar Ramanathan
December 4, 2022: Joanna Strober is on “Yes We Can”
December 1, 2022: Joanna Strober is one of Women of Wearables’ 200 Trailblazing Leaders
November 29, 2022: Midi mentioned as one of the startups seeing a big opportunity in menopause
November 28, 2022: Midi is selected as a member of UCSF Rosenman Institute’s ADAPT cohort
November 21, 2022: ‘Not living with it’: Midi Health focuses on virtual menopause care. Note: membership required for viewing.
November 17, 2022: Joanna Strober shares her passion for creating the best virtual platform for women’s health
November 16, 2022: Solving a healthcare inequity for 57M women
October 27, 2022: Midi launches its platform, supported by $14M in funding
October 17, 2022: Midi is one of the 35 most promising femtech startups, according to VCs. Note: membership required for viewing.
July 6, 2022: All your biggest menopause questions answered
June 14, 2022: Here are some low and no cost tools for companies to help their employees’ mental wellness
June 1, 2022: Joanna Strober quoted as Laddrr, a platform to help ten million moms worldwide advance their careers, launches
May 23, 2022: No matter where you are in life, here’s when to plan checkups and appointments
May 10, 2022: Subscription Stories: Joanna Strober on the ultimate forever transaction: healthcare
May 2, 2022: Women 40+ Deserve Great Healthcare — Care I Couldn’t Find. That’s Why We’re Building Midi Health.
May 2, 2022: Midi pitched as 2022 Telehealth Innovators Challenge Finalist
April 5, 2022: What every woman should know about hormone transition
March 16, 2022: Joanna Strober presents Midi in the HR Transform 2022 Innovation Showcase
June 17, 2021: Many women exit the workforce for a little-talked about reason
October 26, 2020: Suffering in Silence: The biases and data gaps of menopause
July 31, 2020: Global menopausal hot flashes market worth ~$19B by 2027
Click here to read more about Midi Health.
May 1, 2024: How March of Dimes established an innovation fund to further its mission
April 10, 2024: Raydiant FDA Approval for Lumerah Investigational Device Exemption (IDE) Study
March 1, 2024: Raydiant is a finalist in the RADx® Tech Fetal Monitoring Challenge
July 27, 2023: Raydiant is a 2023 Prix Galien USA nominee
June 27, 2023: Four takeaways from Aspen Ideas: Health
May 31, 2023: The Top Founders and Leaders Driving Innovation in Women’s Health in 2023
April 12, 2023: Upcoming webinar to highlight the unseen opportunity in women’s health
February 15, 2023: Raydiant was chosen as a finalist for the Reproductive Health Innovation Showcase
January 25, 2023: Raydiant is pitching at the Future of Maternal Care Summit 2023
November 16, 2022: Raydiant is presenting at the Innovation Summit San Francisco 2022
November 3, 2022: Raydiant partnering with Irish institute to develop life-saving technology
October 17, 2022: Raydiant is one of the 35 most promising femtech startups, according to VCs. Note: membership required for viewing.
September 4, 2022: Raydiant among the 24 startups pitching at the 2022 Women’s Health Innovation Summit
July 28, 2022: Raydiant among the winners of the NIH’s Technology Accelerator Challenge for Maternal Health
June 28, 2022: Lab to Startup: Preventing unnecessary C-sections and making childbirth safer
April 19, 2022: Emerging Startups 2022: Top Wearable Technology Startups
March 14, 2022: Raydiant Oximetry takes unusual path to move its innovative idea forward
March 9, 2022: Innovation Tri-Valley Leadership Group Announces 2022 #GameChanger Awards
February 24, 2022: ‘Femtech’ evolving beyond periods, pregnancy and postpartum: what’s next for women’s health (Note: membership required for viewing.)
December 21, 2021: Raydiant presenting as part of SPIE Startup Challenge
November 23, 2021: Why this medtech startup isn’t afraid of taking on a PMA process with the FDA
November 2, 2021: Raydiant raises $5 million in oversubscribed Series A-2 financing round
May 26, 2021: Raydiant Oximetry receives $3 million grant
April 20, 2021: Raydiant selected by the NIH to present at the Angel Capital Association’s annual conference
April 5, 2021: The truth about electronic fetal heart rate monitoring
September 8, 2020: Raydiant selected for 2020 HealthTech Arkansas healthcare accelerator
August 24, 2020: Between the Term Sheets podcast: Raydiant Oximetry (also available on Apple, Google, and Spotify)
July 21, 2020: MedTech Innovator announces top 15 startups selected for pediatric accelerator program
June 30, 2020: Maternal health in America
May 15, 2020: How much does it cost to give birth in the United States?
October 28, 2019: Raydiant graduates from Fogarty Institute & raises Series A round
September 26, 2019: Raydiant wins pediatric award
April 3, 2019: Which medical devices made the MedCity INVEST pitch competition shortlist?
March 19, 2019: Women’s health is long overdue for a fresh pair of eyes - and needed funding
Click here to read more about Raydiant Oximetry.
August 9, 2023: Uqora recognized as a best place to work in SoCal
June 28, 2023: The six best vitamins and supplements for vaginal health - and how they compare
May 19, 2023: Uqora - Top Ten Most Important Things You Need to Know
May 2, 2023: Uqora launches in-stores
March 9, 2023: Tacos and Tech podcast: Jenna Ryan of Uqora on keeping your urinary tract in check (also available on Google, and Spotify)
December 12, 2022: 25 best vitamins for vaginal health in 2022
November 21, 2022: What do I need to know about UTIs? An expert answers your burning questions
August 11, 2022: Uqora review - I’m a lifelong UTI sufferer and Uqora is seriously a game-changer
July 29, 2022: The six best yeast infection treatments
June 13, 2022: Uqora case study: what it means to be a retention-focused brand
June 11, 2022: Success stories: Jenna Ryan had eight UTIs in one year - so she started her business to help others like her
May 24, 2022: We asked experts how to get rid of a UTI because the symptoms are the worst
March 2, 2022: One women is taking control of her urinary health - here’s how
March 2, 2022: The best pH balance pills and probiotics
February 11, 2022: Best UTI supplements of 2022: the ultimate guide
February 8, 2022: Uqora launches new vulva cleanser
December 8, 2021: Why VCs should set their sights on healthcare products made for (and by) women
November 21, 2021: The second annual National UTI Awareness Day is November 21
September 30, 2021: By solving a painful problem for women, this couple built a fast-growing brand that just got acquired
September 9, 2021: Uqora recognized as one of the best places to work in San Diego
August 5, 2021: Busine$$ of the V podcast: Uqora tackles UTIs in a whole new way
July 8, 2021: Pharmavite announces acquisition of Uqora
July 7, 2021: Chronic UTIs meet their match in Uqora
May 21, 2021: Finally, there’s a new approach to managing urinary tract infections
March 16, 2021: The anatomy of an eCommerce retention manager: Jill Comrie of Uqora
December 11, 2020: Uqora Celebrates Urinary Tract Health
November 21, 2020: National UTI Awareness Day: An Interview with Jenna Ryan
November 18, 2020: Uqora declares November 21 to be the first ever National UTI Awareness Day
November 12, 2020: This CEO had 8 UTIs in One Year - Here’s What She Did About It
October 28, 2020: Innovators Busting Taboos in Women’s Health & Wellness
October 5, 2020: FemTech Focus podcast: Debunking the cranberry myth with Uqora (also available on Apple and Amazon)
September 29, 2020: Uqora develops the first non-antibiotic treatment of UTIs
September 14, 2020: Uqora experiences rapid growth tackling urinary health with innovative solutions and research
July 27, 2020: Uqora launches new line of products
July 13, 2020: The Fifth Wave CEO: Jenna Ryan
May 19, 2020: Exciting upcoming Uqora clinical trial offers hope for thousands of women
April 7, 2020: Founder Feature: Jenna Ryan
January 8, 2020: Uqora conducts clinical trials
October 6, 2019: The Well Woman, Redefined: Jenna Ryan
August 26, 2019: Uqora founder Jenna Ryan on transforming how we talk about UTIs
August 8, 2019: So You Have a UTI. Here’s What to Do Next
December 3, 2018: This entrepreneur is out to end the UTI stigma
Click here to read more about Uqora.
January 17, 2024: ViuHealth partners with The Leaders Rheum
October 10, 2022: DrugViu is now ViuHealth
August 19, 2021: Next Wave Impact Network invests $500,000 in 2021 Founders of Color Showcase winners
July 23, 2021: DrugViu in conversation about diversity in clinical trials and healthcare
July 16, 2021: DrugViu launches Autoimm[you]ne Podcast
April 20, 2021: DrugViu announced as a finalist for Founders of Color Showcase
April 14, 2021: DrugViu announced as semifinalist for Founders of Color Showcase
March 24, 2021: Coral Genomics partners with DrugViu
March 23, 2021: Riverflow Investments and Metrodora Ventures lead DrugViu’s latest financing round
March 2, 2021: DrugViu is relocating to and expanding operations in North Virginia
February 18, 2021: The power of diverse patient data: an interview with Kwaku Owusu
January 17, 2021: Amplifying scientific innovation with Kwaku Owusu, co-founder & CEO, DrugViu
December 29, 2020: Watch DrugViu pitch at MedCity INVEST Precision Medicine: Health IT track
October 7, 2020: DrugViu selected for gBETA Medtech fall cohort 2020
December 12, 2019: PM360 presents the 2019 innovators
November 11, 2019: DrugViu wins the QBE and Ashoka Urban Resilience Challenge
October 24, 2019: DrugViu wins $75,000 to bring relevant healthcare information to people of color
October 9, 2019: 10 startups pitch at Techstars Impact Demo Day in Austin
June 19, 2019: Increasing diversity in clinical trials: a conversation with Kwaku Owusu
We update this page regularly. Keep checking back for the latest news on our portfolio companies.